Completion of this activity will allow learners to discuss the mechanism of delivering radioactive drugs to the tumors based on the Theranostic Nuclear Medicine paradigm; discuss the current treatment options that work according to the Theranostic Nuclear Medicine paradigm; and discuss the optimal applications for Theranostic Nuclear Medicine in clinical practice. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to develop a differential diagnosis of lymphadenopathy; Identify effective tools to assist in the diagnosis of lymphadenopathy; and explain general management strategies for patients with lymphadenopathy. This activity is worth 1.0 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to discuss medication and surgical errors, misdiagnoses and system failures; discuss creating a culture of safety, root cause analysis, error reduction and prevention, and patient safety; and review most common errors as defined by the FL-BOOM. This activity is worth 2.0 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to compare and contrast examples of controlled substance schedules and their relevant prescribing limitations; explain the underlying background behind the current opioid epidemic; and describe alternative pharmacologic and non-pharmacologic options for treating pain aside from the use of opioids. This activity is worth 1.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to define the role of palliative care in oncology and how it differentiates from hospice care including evolution of the prognostic conversation; describe the evidence based value of early palliative care in medical oncology practice; and discuss barriers to palliative care integration into standard oncology practice. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.